Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres

American Journal of Roentgenology

Volumn 188, Issue 3, 2007, Pages 768-775

  Keppke, Ana L ^a   Salem, Riad ^a   Reddy, Denise ^a   Huang, Jie ^a   Jin, Jianhua ^a   Larson, Andrew C ^a   Miller, Frank H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Abdominal imaging; Brachytherapy; CT; Hepatocellular carcinoma; Interventional radiology; Liver; Oncologic imaging; Radioembolization; Yttrium 90

Indexed keywords

MICROSPHERE; YTTRIUM 90;

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; RADIOISOTOPE DIAGNOSIS; TISSUE NECROSIS; TREATMENT OUTCOME;

ADULT; AGED; BRACHYTHERAPY; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; ILLINOIS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; NECROSIS; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 33847200442     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.06.0706     Document Type: Article

References (31)

1. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 1985; 56:918-928
2. Pawarode A, Tangkijvanich P, Voravud N. Outcomes of primary hepatocellular carcinoma treatment: an 8-year experience with 368 patients in Thailand. J Gastroenterol Hepatol 2000; 15:860-864
3. Herold C, Reck T, Fischler P, et al. Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European center. Liver 2002; 22:23-28
4. El-Serag HB, Mason AC, Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 2001; 33:62-65
5. Geschwind JF, Salem R, Carr BI, et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 2004; 127[5 suppl 1]:S194-S205
6. Salem R, Thurston KG, Carr BI, Goin JE, Geschwind JF. Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol 2002; 13(9 Pt 2):S223-S229
7. 90yttrium microspheres. Int J Radiat Oncol Biol Phys 1998; 40:583-592
8. Liu MD, Uaje MB, Al-Ghazi MS, et al. Use of yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma. Am Surg 2004; 70:947-953
9. Carr BI. Hepatic arterial 90 yttrium glass microspheres (TheraSphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 2004; 10[2 suppl 1]:S107-S110
10. 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 2005; 16:1627-1639
11. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47:207-214
12. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92:205-216
13. Overmoyer BA, McLaren CE, Brittenham GM. Uniformity of liver density and nonheme (storage) iron distribution. Arch Pathol Lab Med 1987; 111:549-554
14. 18F] fluorodeoxyglucose positron emission tomography and computed tomographic imaging. J Vasc Interv Radiat 2005; 16:1641-1651
15. Goin JE, Salem R, Carr BI, et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium-90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiat 2005; 16:205-213
16. Goin JE, Dancey JE, Roberts CA, Sickles CJ, Leung DA, Soulen MC. Comparison of post-embolization syndrome in the treatment of patients with unresectable hepatocellular carcinoma: trans-catheter arterial chemo-embolization versus yttrium-90 glass microspheres. World J Nucl Med 2004; 3:49-56
17. 18F] FDG PET: a comparison with CT or MRI. Eur J Nucl Med Mol Imaging 2002; 29:815-820
18. Torizuka T, Tamaki N, Inokuma T, et al. Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. J Nucl Med 1994; 35:1965-1969
19. Takayasu K, Arii S, Matsuo N, et al. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR 2000; 175:699-704
20. Ebied OM, Federle MP, Carr BI, et al. Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma. Cancer 2003; 97:1042-1050
21. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001; 35:421-430
22. Llovet JM, Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol 2003; 38[suppl 1]:S136-S149
23. Kuszyk BS, Boitnott JK, Chou M A, et al. Local tumor recurrence following hepatic cryoablation: radiologic-histopathologic correlation in a rabbit model. Radiology 2000; 217:477-486
24. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR 1998; 170:1015-1022
25. Shiina S, Tagawa K, Unuma T, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: a histopathologic study. Cancer 1991; 68:1524-1530
26. Dromain C, de Baere T, Elias D, et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 2002; 223:255-262
27. Bartolozzi C, Lencioni R, Caramella D, Mazzeo S, Ciancia EM. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging. AJR 1994; 162:827-831
28. 90Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 2004; 60:1552-1563
29. Houle S, Yip TK, Shepherd FA, et al. Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres. Radiology 1989; 172:857-860
30. Tsuda M, Majima K, Yamada T, Saitou H, Ishibashi T, Takahashi S. Hepatocellular carcinoma after radiofrequency ablation therapy: dynamic CT evaluation of treatment. Clin Imaging 2001; 25:409-415
31. Salem R, Lewandowski R, Roberts C, et al. Use of yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 2004; 15:335-345